These data suggest that mechanisms, likely including DNA methylation, exist in normal cells to reduce the expression of CXCR4. Thus, cancer progression could lead to the demethylation of the CXCR4 promoter to selectively favor tumor growth and cell migration. Here, CXCR4 is linked to neoplasm.